Business News • MarketWire • Equity Research on Bristol-Myers Squibb Co. and AstraZeneca plc - Pricing and Expiring Patents Threaten Revenues for Drug Manufacturers

Equity Research on Bristol-Myers Squibb Co. and AstraZeneca plc - Pricing and Expiring Patents Threaten Revenues for Drug Manufacturers

Equity Research on Bristol-Myers Squibb Co. and AstraZeneca plc - Pricing and Expiring Patents Threaten Revenues for Drug Manufacturers

JOHANNESBURG, SOUTH AFRICA--(Marketwire - February 1, 2011) - www.stockcall.com/ offers investors comprehensive research on the drug manufacturers - major industry and has completed analytical research on Bristol-Myers Squibb Co. (NYSE: BMY) and AstraZeneca plc (NYSE: AZN). Register with us today at www.stockcall.com/ to have free access to these researches.

View More : http://www.marketwire.com/mw/release.do?id=1388269&sourceType=3

Releted News by marketwire

Global Earth Energy, Inc. Announces Agreement to Invest by LB Tim Co., Ltd. of South Korea

Analyst Research on AFLAC Inc. and Unum Group - Sneak Peek in the Accident & Health Insurance Industry